Canada Markets closed

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
38.35+0.30 (+0.79%)
At close: 04:00PM EST
38.10 -0.25 (-0.65%)
After hours: 07:28PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.93
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3130.33
52 Week Low 337.08
50-Day Moving Average 351.62
200-Day Moving Average 357.44

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 31.78M
Shares Outstanding 574.42M
Implied Shares Outstanding 6N/A
Float 871.03M
% Held by Insiders 19.72%
% Held by Institutions 188.59%
Shares Short (Oct 13, 2022) 46.58M
Short Ratio (Oct 13, 2022) 45.24
Short % of Float (Oct 13, 2022) 49.95%
Short % of Shares Outstanding (Oct 13, 2022) 48.66%
Shares Short (prior month Sept 14, 2022) 46.68M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-849.04%

Management Effectiveness

Return on Assets (ttm)-26.99%
Return on Equity (ttm)-58.23%

Income Statement

Revenue (ttm)45.34M
Revenue Per Share (ttm)0.61
Quarterly Revenue Growth (yoy)114.20%
Gross Profit (ttm)-186.75M
EBITDA -377.7M
Net Income Avi to Common (ttm)-400.43M
Diluted EPS (ttm)-2.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)874.28M
Total Cash Per Share (mrq)11.5
Total Debt (mrq)69.56M
Total Debt/Equity (mrq)7.90
Current Ratio (mrq)7.24
Book Value Per Share (mrq)7.96

Cash Flow Statement

Operating Cash Flow (ttm)-284.56M
Levered Free Cash Flow (ttm)-172.59M